Beyond the Acute Phase: Long-Term Impact of COVID-19 on Functional Capacity and Prothrombotic Risk—A Pilot Study
Authors:
- Doina-Clementina CojocaruDCDoina-Clementina Cojocaru
- Florin MituFlorin Mitu
- Maria-Magdalena LeonMLMaria-Magdalena Leon
- Lucia Corina Dima-CozmaLDLucia Corina Dima-Cozma
- Cristina Andreea AdamCACristina Andreea Adam
- Carmen Marinela CumpătCCCarmen Marinela Cumpăt
- Robert D. NegruRNRobert D. Negru
- Alexandra MaștaleruAMAlexandra Maștaleru
- Viviana OnofreiVOViviana Onofrei
Open Access
Abstract
Background and Objectives: Assessment of the prothrombotic, proinflammatory, and functional status of a cohort of COVID-19 patients at least two years after the acute infection to identify parameters with potential therapeutic and prognostic value. Materials and Methods: We conducted a retrospective, descriptive study that included 117 consecutive patients admitted to Iasi Pulmonary Rehabilitation Clinic for reassessment and a rehabilitation program at least two years after a COVID-19 infection. The cohort was divided into two groups based on the presence (n = 49) or absence (n = 68) of pulmonary fibrosis, documented through high-resolution computer tomography. Results: The cohort comprises 117 patients, 69.23% females, with a mean age of 65.74 ± 10.19 years and abnormal body mass index (31.42 ± 5.71 kg/m2). Patients with pulmonary fibrosis have significantly higher levels of C-reactive protein (CRP) (p < 0.05), WBC (7.45 ± 7.86/mm3 vs. 9.18 ± 17.24/mm3, p = 0.053), neutrophils (4.68 ± 7.88/mm3 vs. 9.07 ± 17.44/mm3, p < 0.05), mean platelet volume (MPV) (7.22 ± 0.93 vs. 10.25 ± 0.86 fL, p < 0.05), lactate dehydrogenase (p < 0.05), and D-dimers (p < 0.05), but not ferritin (p = 0.470), reflecting the chronic proinflammatory and prothrombotic status. Additionally, patients with associated pulmonary fibrosis had a higher mean heart rate (p < 0.05) and corrected QT interval (p < 0.05). D-dimers were strongly and negatively correlated with diffusion capacity corrected for hemoglobin (DLCO corr), and ROC analysis showed that the persistence of high D-dimers values is a predictor for low DLCO values (ROC analysis: area under the curve of 0.772, p < 0.001). The results of pulmonary function tests (spirometry, body plethysmography) and the 6-minute walk test demonstrated no significant difference between groups, without notable impairment within either group. Conclusions: Patients with COVID-19-related pulmonary fibrosis have a persistent long-term proinflammatory, prothrombotic status, despite the functional recovery. The persistence of elevated D-dimer levels could emerge as a predictive factor associated with impaired DLCO.Keywords
This publication has 58 references indexed in Scilit:
- Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategiesClinical Medicine, 2021
- Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19Canadian Medical Association Journal, 2020
- First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020Eurosurveillance, 2020
- Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical StatementAmerican Journal of Respiratory and Critical Care Medicine, 2019
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDEuropean Heart Journal, 2019
- 2018 ESC/ESH Guidelines for the management of arterial hypertensionEuropean Heart Journal, 2018
- Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2011
- Body plethysmography – Its principles and clinical useRespiratory Medicine, 2011
- Updates on Definition, Consequences, and Management of Obstructive Sleep ApneaMayo Clinic Proceedings, 2011
- Reference values for the 6-min walk test in healthy subjects 20–50 years oldRespiratory Medicine, 2006